PRFX - EXCLUSIVE: PainReform Reaches 50% Enrollment Target For Phase 3 Study For Its Lead Postoperative Pain Drug | Benzinga
On Tuesday, PainReform Ltd (NASDAQ:PRFX) announced it reached the 50% enrollment target for the second part of the Phase 3 clinical trial of PRF-110 in bunionectomy.
A bunion is a bony bump that forms at the base of the big toe, forming a union with a foot bone called the first metatarsal. The bunion is a foot deformity comprising bone and soft tissue.
Bunion removal is a surgical procedure that corrects a deformed area of the foot near the big toe. Bunion removal is sometimes called a bunionectomy, ...